GeneThera, Inc.
CIK 0001017110
Revenue (TTM)
$0
Q3 Nov 2022
Net Income (TTM)
−$650.12K
−30.6% YoY
Q3 Nov 2022
EPS Diluted (TTM)
−$0.04
+33.3% YoY
Q3 Nov 2022
Gross Margin
—
Q3 Nov 2022
Operating Margin
—
Q3 Nov 2022
Net Margin
—
Q3 Nov 2022
Free Cash Flow (TTM)
−$26.94K
Q3 Nov 2022
Cash
$0
Q3 Nov 2022
Total Debt
—
Q3 Nov 2022
Shares Outstanding
35.33M sh
Q3 Nov 2022
Revenue & Net Income
EPS (Diluted)
Cash Flow
Revenue Growth (YoY)
No data available for this metric.